Collaborative Information Site

User Profile @Harneedi

follow: RSS


Harneedi's Posts

Know about the hospital based MRSA infection

Hospitals are only for patients not for Visitors:

The Indian culture is such that it values relations and gives much importance to friends, family and social relations hence when ever we have moments of happiness, joy or sadness, sorrows, people gather in large number shows their solidarity to the individual and the family in general. Hence we have twice or even more the number of visitors than patients in a hospital. Troubled with these overwhelming number of visitors many new generation private hospitals have curbed the visiting time to minutes, but still people crowd around hospitals and wards putting their lives too in jeopardy by coming in direct contact with deadly strains of bacteria and viruses that are too common in hospitals.

One such bacteria is Methicillin-resistant Staphylococcus aureus (MRSA), a dangerous bacteria which causes skin infections, in addition to skin infections, the bacteria will also cause many other types of deadly infections. There are several other vari

continue reading
1 visits |0 Comments

The major investments in the Indian pharmaceutical sector

Indian pharmaceuticals market is expected to touch US $55 billion by 2020 from the current level of US $36.7 billion in 2016 growing at a compound annual growth rate (CAGR) of 15.92%, according to ASSOCHAM-IITTM joint study.

Indian pharmaceuticals market increased at a CAGR of 17.46% during 2005-16 with the market increasing from US $6 billion in 2005 to US $36.7 billion in 2016.

By 2020, India is likely to be among the top 3 pharmaceutical markets in terms of incremental growth and 6th largest market globally in terms of absolute size, noted the study titled ‘Medical Value Travel (MVT),’ jointly conducted by ASSOCHAM and research firm, Indian Institute of Tourism and Travel Management (IITTM).

Continue Reading @ http://bit.ly/2zV7m3h

For more updates visit HarNeedi.com

 

continue reading
1 visits |0 Comments

Management and Handling rules of Biomedical waste

Whereas a notification in exercise of the powers conferred by Sections 6, 8 and 25 of the Environment (Protection) Act, 1986 (29 of 1986) was published in the Gazette vide S.O. 746 (E) dated 16th October 1997 inviting objections from the public within 60 days from the date of publication of the said notification on the Biomedical Waste (Management and Handling) Rules, 1998 and whereas all objections received were duly considered;

Now therefore, in exercise of the powers conferred by section 6, 8 and 25 of the Environment (Protection) Act, 1986 the Central Government hereby notifies the Rules for the management and handling of the biomedical waste.

1. SHORT TITLE AND COMMENCEMENT:

These rules may be called the Biomedical Waste (Management and Handling) Rules, 1998.They shall come into force on the date of their publication in the official Gazette.

Continue Reading @ http://bit.ly/2NjkbpE

For more updates visit HarNeedi.com

 

 

continue reading
1 visits |0 Comments

Benefits from Digital health technologies for Pharma

India is the biggest manufacturer and exporter of generic drugs on globe and considered as the pharmacy of the globe. However many Indian pharma companies find it difficult to survive in global markets due to the heavy competition, lack of market research knowledge, complex regulatory results and not embracing the latest digital technologies adopted by global companies.

Innovation brings both opportunity and change, and this is true with emerging point of care technology. There is a pressing need for help in the three critical areas of Prevention, Diagnosis and Monitoring.But extremely restrictive regulations, the presence of multiple key stakeholders, a slow-to-adopt culture and other challenges distinguish healthcare from the retail and finance sectors, which have flourished with their implementations of digital technologies. 

Continue Reading @ http://bit.ly/2L3Zm0O

For more updates visit HarNeedi.com

continue reading
2 visits |0 Comments

Initiatives and challenges of Indian Healthcare market

Indian healthcare - Market size, investments, Govt.Of India Initiatives and challenges: 

If there has been a cheerful sector, impulsive employment sources and revenue genesis for India, it is healthcare sector and there is no doubt in it! With a high demand for healthcare services in India, rising the need for innovative healthcare, medical care facilities, medical tourism and state governments, Government of India concentrating for medical care evolutions, the overall sector has been repelling the job market, at the same time as others have recede and progressed freely. This week updates describe Indian healthcare – Market size, investments, Government Initiatives and challenges.

Continue Reading @ http://bit.ly/2N3WyBo

For more updates visit HarNeedi.com

 

continue reading
1 visits |0 Comments

Biopharma environment VS Medical Professionals

A career shift from medical practice into the biopharma industry is springing up for various medical doctors. Job opportunities exist for all specialist medical doctors and surgeons. These medical professionals engaged in the process of discovery, development, marketing of drugs, vaccines / devices. With this transition (from clinical practice to biopharma industry) gave a greater work-life balance for doctors and provided a chance to impingement the health of patients on a global scale or an opportunity to originate better treatment options for rare/critical diseases. In spite of anything, there are many things to be learned by newly migrating medical professionals while journey in the drug research.

Continue Reading @ https://bit.ly/2KrveiU

For more updates visit HarNeedi.com

continue reading
1 visits |0 Comments

Overview of Biotechnology career and scope

Biotechnology Career options:

I am now convinced that what began as biotechnology bandwagon some fifteen years ago has developed some valuable new scientific methodologies and products which need active financial and organisational support to bring them to fruition in food and fibre production systems. Norman E Borlaug

What is Biotechnology?

It is difficult to define Biotechnology as a specific sector or industry. The conventional definition of biotechnology includes work on processes and products at sub-organism levels (tissue, cell and molecule). Some would even identify biotechnology exclusively with genetic engineering. A much widely accepted definition is "Biotechnology is any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use. When interpreted broadly, biotechnology can therefore include traditional methods, for example in improving domesticated plants and animals by breedin

continue reading
3 visits |0 Comments

Opportunities galore in Healthcare Industries

The Indian healthcare industry has not witnessed any sort of downsizing or negative trend during this recession, unlike other industries like the Automotive, manufacturing or Real-estate, that had a direct impact. There had been a steady growth in this sector, revenues from the healthcare sector accounts for 5.2% of the GDP, making it the third largest growing sector in India, and further the healthcare sector is projected to grow to nearly 40 billion US dollars by year 2012.

Taking the entire healthcare industry into account, the sectors that have tremendous growth potential are Medical Infrastructure, Telemedicine, Medical Equipment, Medical Textiles, Health Insurance, Clinical Trials, Medical Services Outsourcing, Medical Tourism, and Training & Education, which are the most important ones that offer numerous opportunities.

Click here to Continue Reading 

For more updates visit HarNeedi.com

continue reading
1 visits |0 Comments

Effective Physician and Patient interaction

Being a good physician means more than simply being a good clinician. Doctors in their day-to-day activities can provide leadership to their fellow workers and vision for the organisations in which they work for and also to the profession as a whole. However, still doctors are willing to contribute to improving the quality of services and to opine when things are wrong, patient care is likely to suffer in these situations. Relationships grounded on openness, trust and good communication will enable doctors to work in partnership with their patients to address the needs.

To fulfil doctor role in the Doctor vs Patient Relationship, doctor must:

  • Be polite, considerate and honest to their patients
  • Consider every patient as an individual
  • Honor patients' privacy and right to secrecy
  • Treat patients with dignity
  • Give courage to patients in caring for themselves to improve and maintain health

 

Click here to continue reading

For more updates visit HarNeedi.com

continue reading
2 visits |0 Comments

Regulatory Challenges in Global Clinical Trials

In the new patent era pharmaceutical companies have changed their strategy to market their products. They are launching products in multiple markets with a single shot to capture their share. In order to get an approval for marketing of their product, regulatory bodies are insisting on clinical trials of land for the safety concerns of the people of their region and suspecting and questioning the efficacy of the product.

In this scenario, the pharmaceutical companies are bound to go for global clinical trials. In contrast to routine trials, there are multiple technical, procedural, and legal hurdles in conducting global clinical trials varying from site selection to regulatory clearances to precede a trial.

Let’s discuss some of the important issues. In this situation one has to go with global thinking with local regulatory process awareness.

Continue Reading @ https://bit.ly/2IEHh8f

For more updates visit HarNeedi.com

continue reading
2 visits |0 Comments
[]